Literature DB >> 30247462

A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts.

Lianxiang Bi1, Bradley K Wacker1, David A Dichek2.   

Abstract

Vein graft bypass surgery is a common treatment for occlusive arterial disease; however, long-term success is limited by graft failure due to thrombosis, intimal hyperplasia, and atherosclerosis. The goal of this article is to demonstrate a method for placing bilateral venous interposition grafts in a rabbit, then transducing the grafts with a gene transfer vector that achieves durable transgene expression. The method allows the investigation of the biological roles of genes and their protein products in normal vein graft homeostasis. It also allows the testing of transgenes for the activities that could prevent vein graft failure, e.g., whether the expression of a transgene prevents the neointimal growth, reduces the vascular inflammation, or reduces atherosclerosis in rabbits fed with a high-fat diet. During an initial survival surgery, the segments of right and left external jugular vein are excised and placed bilaterally as reversed end-to-side common carotid artery interposition grafts. During a second survival surgery, performed 28 days later, each of the grafts is isolated from the circulation with vascular clips and the lumens are filled (via an arteriotomy) with a solution containing a helper-dependent adenoviral (HDAd) vector. After a 20-min incubation, the vector solution is aspirated, the arteriotomy is repaired, and flow is restored. The veins are harvested at time points dictated by individual experimental protocols. The 28-day delay between the graft placement and the transduction is necessary to ensure the adaptation of the vein graft to the arterial circulation. This adaptation avoids rapid loss of transgene expression that occurs in vein grafts transduced before or immediately after grafting. The method is unique in its ability to achieve durable, stable transgene expression in grafted veins. Compared to other large animal vein graft models, rabbits have advantages of low cost and easy handling. Compared to rodent vein graft models, rabbits have larger and easier-to-manipulate blood vessels that provide abundant tissue for analysis.

Entities:  

Mesh:

Year:  2018        PMID: 30247462      PMCID: PMC6235117          DOI: 10.3791/57231

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  42 in total

1.  Adenoviral-mediated gene transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts.

Authors:  L B Schwartz; J Moawad; E C Svensson; R L Tufts; S L Meyerson; D Baunoch; J M Leiden
Journal:  J Vasc Surg       Date:  1999-05       Impact factor: 4.268

2.  Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice.

Authors:  Daniël Eefting; Ilze Bot; Margreet R de Vries; Abbey Schepers; J Hajo van Bockel; Theo J C Van Berkel; Erik A L Biessen; Paul H A Quax
Journal:  J Vasc Surg       Date:  2009-07       Impact factor: 4.268

3.  Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels.

Authors:  K M Channon; G J Fulton; J L Gray; B H Annex; G A Shetty; M A Blazing; K G Peters; P O Hagen; S E George
Journal:  Cardiovasc Res       Date:  1997-09       Impact factor: 10.787

4.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

5.  Quantification of in-stent restenosis parameters in rabbits by Micro-CT.

Authors:  A C Langheinrich; C Zoerb; J Jajima; D Lommel; G Walker; K-M Mueller; W S Rau; R M Bohle
Journal:  Rofo       Date:  2005-04

6.  Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis.

Authors:  Rowan Flynn; Kun Qian; Chongren Tang; Nagadhara Dronadula; Joshua M Buckler; Bo Jiang; Shan Wen; Helén L Dichek; David A Dichek
Journal:  Mol Ther       Date:  2011-07-19       Impact factor: 11.454

7.  Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model.

Authors:  Geoffrey T L Kloppenburg; Gert E Grauls; Cathrien A Bruggeman; Frank R Stassen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-10-14

8.  In vivo modulation of Nogo-B attenuates neointima formation.

Authors:  Angelika B Kritz; Jun Yu; Paulette L Wright; Song Wan; Sarah J George; Crawford Halliday; Ning Kang; William C Sessa; Andrew H Baker
Journal:  Mol Ther       Date:  2008-09-09       Impact factor: 11.454

9.  Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors.

Authors:  Michael Chorny; Ilia Fishbein; Jillian E Tengood; Richard F Adamo; Ivan S Alferiev; Robert J Levy
Journal:  FASEB J       Date:  2013-02-13       Impact factor: 5.191

10.  Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector.

Authors:  K Oka; C E Mullins; R S Kushwaha; A M Leen; L Chan
Journal:  Gene Ther       Date:  2014-09-18       Impact factor: 5.250

View more
  1 in total

1.  Response by Dichek to Letter Regarding Article, "Jugular Vein Injection of High-Titer Lentiviral Vectors Does Not Transduce the Aorta".

Authors:  David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-24       Impact factor: 8.311

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.